What are the indications for empiric antibiotics in diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Empiric antibiotics are generally not recommended for most cases of acute diarrhea, and should only be used in specific situations where the benefits outweigh the risks, as indicated by the most recent guidelines from the Infectious Diseases Society of America 1. The indications for empiric antibiotics in diarrhea include:

  • Severe traveler's diarrhea: Use azithromycin 1000 mg single dose or 500 mg daily for 3 days, as recommended by the guidelines for the prevention and treatment of travelers' diarrhea 1.
  • Suspected cholera: Use doxycycline 300 mg single dose or azithromycin 1 gram single dose, as recommended by the guidelines for the diagnosis and management of infectious diarrhea 1.
  • Moderate to severe Clostridium difficile infection: Use oral vancomycin 125 mg four times daily for 10 days, as recommended by the guidelines for the diagnosis and management of infectious diarrhea 1.
  • Suspected shigellosis with high fever or bloody diarrhea: Use ciprofloxacin 500 mg twice daily for 3 days, as recommended by the guidelines for the diagnosis and management of infectious diarrhea 1.
  • Immunocompromised patients with severe symptoms: Consider empiric treatment based on likely pathogens, as recommended by the guidelines for the diagnosis and management of infectious diarrhea 1. It is essential to note that antibiotics should be avoided in most cases of acute diarrhea because they can prolong bacterial shedding, alter gut flora, and increase the risk of antibiotic resistance, as highlighted by the guidelines for the prevention and treatment of travelers' diarrhea 1 and the guidelines for the diagnosis and management of infectious diarrhea 1. Some key points to consider when deciding on empiric antibiotic treatment for diarrhea include:
  • The severity of the illness and the impact on the patient's daily activities
  • The likelihood of treatment efficacy and rapidity of response
  • Regional patterns of probable target pathogens and their antimicrobial resistance
  • Safety and tolerance profile of the antibiotic
  • Simplicity of treatment regimen and patient adherence
  • Cost of treatment As recommended by the guidelines for the prevention and treatment of travelers' diarrhea 1 and the guidelines for the diagnosis and management of infectious diarrhea 1, it is crucial to always obtain stool cultures before starting antibiotics when possible and to consider the potential risks and benefits of treatment in each individual case.

From the FDA Drug Label

Infectious Diarrhea caused by Escherichia coli (enterotoxigenic strains), Campylobacter jejuni, Shigella boydii†, Shigella dysenteriae, Shigella flexneri or Shigella sonnei† when antibacterial therapy is indicated.

The indications for empiric antibiotics in diarrhea are for the treatment of infectious diarrhea caused by specific bacteria, including:

  • Escherichia coli (enterotoxigenic strains)
  • Campylobacter jejuni
  • Shigella species (including Shigella boydii, Shigella dysenteriae, Shigella flexneri, and Shigella sonnei) when antibacterial therapy is indicated 2.

From the Research

Indications for Empiric Antibiotics in Diarrhea

The following are indications for empiric antibiotics in diarrhea:

  • Fever and/or bloody diarrhea 3, 4, 5
  • Patients at risk, such as those with severe comorbidities, immunodeficiency, or a history of antibiotic exposure within the last 3 months 3, 4, 6
  • Traveler's diarrhea with fever, bloody diarrhea, prolonged course of disease (more than 5 days), severe clinical course with hypotension or dehydration, or during outbreaks 3, 7
  • Severe invasive or prolonged diarrhea 6
  • High-risk individuals, such as the elderly, diabetics, cirrhotics, and immunocompromised patients 6

Specific Patient Populations

  • Immunocompetent patients do not require specific antibiotic therapy, except in cases of Shigella or C. difficile infection 3
  • Patients with Shigella or C. difficile infection should receive empirical antibiotic treatment 3, 4
  • Patients with traveler's diarrhea may require microbiological diagnosis and empirical antibiotic treatment, depending on the severity of symptoms and risk factors 3, 7

Antibiotic Choices

  • Azithromycin or ciprofloxacin are recommended for empiric treatment of diarrhea, taking into account local antimicrobial resistance and possible side effects 3
  • Fluoroquinolones, such as ciprofloxacin, may be considered as first-line therapy for traveler's diarrhea 7
  • Metronidazole is indicated for C. difficile colitis 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antimicrobial therapy of acute diarrhoea: a clinical review.

Expert review of anti-infective therapy, 2016

Research

Therapy of acute gastroenteritis: role of antibiotics.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2015

Research

The role of antibiotics in the treatment of infectious diarrhea.

Gastroenterology clinics of North America, 2001

Research

Traveler's diarrhea.

American family physician, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.